David Tuveson is Director of the Cancer Center and the Roy J. Zuckerberg Professor of Cancer Research, at Cold Spring Harbor Laboratory, Chief Scientist at the Lustgarten Foundation, and Past-President of AACR. David obtained a bachelor’s degree in chemistry at M.I.T., followed by an MD and Ph.D. at Johns Hopkins. He was a medical resident at Brigham and Women’s Hospital and a medical oncology fellow at Dana-Farber/Harvard Cancer Center. During his post-doctoral years in Boston, David co-developed KIT inhibitors for gastrointestinal stromal tumors with Dr. George Demetri. Simultaneously, he generated several widely used mouse cancer models with Dr. Tyler Jacks. As an independent investigator, David’s lab developed the first mouse models of ductal pancreatic cancer at the University of Pennsylvania. Subsequently, he was recruited to the University of Cambridge, UK, where his lab identified poor drug delivery as a barrier to therapeutic efficacy in pancreatic cancer. He was then recruited to Cold Spring Harbor Laboratory (CSHL) as the Deputy Director of the Cancer Center and to serve as Director of Research for the Lustgarten Foundation.
This person is not in the org chart